Medtronic (MDT)

NYSE Health Care Health Care Equipment S&P 500

$101.80

-3.04 (-2.90%)

Close of Nov 06, 2026 · end-of-day data

Source: Medtronic's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$29.71B	$29.95B	$30.56B	$28.91B	$30.12B	$31.69B	$31.23B	$32.36B	$33.54B	$36.36B
Cost of revenue	$9.29B	$9.07B	$9.15B	$9.42B	$10.48B	$10.14B	$10.72B	$11.22B	$11.63B	$12.72B
Gross profit	$20.42B	$20.90B	$21.40B	$19.49B	$19.63B	$21.54B	$20.51B	$21.15B	$21.91B	$23.64B
Research & development	$2.19B	$2.26B	$2.33B	$2.33B	$2.49B	$2.75B	$2.70B	$2.73B	$2.73B	$2.87B
Selling, general & admin	$10.02B	$10.24B	$10.42B	$10.11B	$10.15B	$10.29B	$10.41B	$10.74B	$10.85B	$11.78B
Operating income	$5.38B	$6.64B	$6.27B	$4.79B	$4.48B	$5.75B	$5.49B	$5.14B	$5.96B	$6.47B
Interest expense	$1.09B	$1.15B	$1.44B	$1.09B	$925.00M	$553.00M	$636.00M	$719.00M	$729.00M	$715.00M
Pre-tax income	$4.60B	$5.67B	$5.20B	$4.05B	$3.90B	$5.52B	$5.36B	$4.84B	$5.63B	$6.14B
Income tax	$578.00M	$2.58B	$547.00M	-$751.00M	$265.00M	$456.00M	$1.58B	$1.13B	$936.00M	$1.30B
Net income	$4.03B	$3.10B	$4.63B	$4.79B	$3.61B	$5.04B	$3.76B	$3.68B	$4.66B	$4.80B
EBITDA	$8.30B	$9.28B	$8.93B	$7.45B	$7.19B	$8.46B	$8.18B	$7.79B	$8.82B	$9.43B
EPS (basic)	$2.92	$2.29	$3.44	$3.57	$2.68	$3.75	$2.83	$2.77	$3.63	$3.75
EPS (diluted)	$2.89	$2.27	$3.41	$3.54	$2.66	$3.73	$2.82	$2.76	$3.61	$3.73
Diluted shares	1.39B	1.37B	1.36B	1.35B	1.35B	1.35B	1.33B	1.33B	1.29B	1.29B
Gross margin	68.7%	69.8%	70.0%	67.4%	65.2%	68.0%	65.7%	65.3%	65.3%	65.0%
Operating margin	18.1%	22.2%	20.5%	16.6%	14.9%	18.2%	17.6%	15.9%	17.8%	17.8%
Net margin	13.6%	10.4%	15.2%	16.6%	12.0%	15.9%	12.0%	11.4%	13.9%	13.2%

Balance sheet

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash & equivalents	$4.97B	$3.67B	$4.39B	$4.14B	$3.59B	$3.71B	$1.54B	$1.28B	$2.22B	$1.95B
Short-term investments	$8.74B	$7.56B	$5.46B	$6.81B	$7.22B	$6.86B	$6.42B	$6.72B	$6.75B	$7.27B
Receivables	$5.59B	$5.99B	$6.22B	$4.64B	$5.46B	$5.55B	$6.00B	$6.13B	$6.51B	$6.64B
Inventory	$3.34B	$3.58B	$3.75B	$4.23B	$4.31B	$4.62B	$5.29B	$5.22B	$5.48B	$5.95B
Total current assets	$24.87B	$22.98B	$21.97B	$22.03B	$22.55B	$23.06B	$21.68B	$21.93B	$23.81B	$24.79B
Goodwill	$38.52B	$39.54B	$39.96B	$39.84B	$41.96B	$40.50B	$41.42B	$40.99B	$41.74B	$42.59B
Total assets	$99.86B	$91.39B	$89.69B	$90.69B	$93.08B	$90.98B	$90.95B	$89.98B	$91.68B	$93.03B
Total current liabilities	$14.26B	$10.08B	$8.47B	$10.37B	$8.51B	$12.39B	$9.05B	$10.79B	$12.88B	$11.66B
Short-term debt	$7.52B	$2.06B	$838.00M	$2.78B	$11.00M	$3.74B	$20.00M	$1.09B	$2.87B	$1.79B
Long-term debt	$25.87B	$23.69B	$24.55B	$22.14B	$26.38B	$20.37B	$24.34B	$23.93B	$25.64B	$26.17B
Total debt	$33.39B	$25.75B	$25.39B	$24.92B	$26.39B	$24.11B	$24.36B	$25.02B	$28.52B	$27.96B
Total liabilities	$49.53B	$40.57B	$39.48B	$39.82B	$41.48B	$38.26B	$39.28B	$39.56B	$43.42B	$42.96B
Shareholders' equity	$50.21B	$50.72B	$50.09B	$50.74B	$51.43B	$52.55B	$51.48B	$50.21B	$48.02B	$49.46B

Cash flow

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Operating cash flow	$6.88B	$4.68B	$7.01B	$7.23B	$6.24B	$7.35B	$6.04B	$6.79B	$7.04B	$7.33B
Capital expenditures	$1.25B	$1.07B	$1.13B	$1.21B	$1.35B	$1.37B	$1.46B	$1.59B	$1.86B	$1.90B
Free cash flow	$5.63B	$3.62B	$5.87B	$6.02B	$4.88B	$5.98B	$4.58B	$5.20B	$5.18B	$5.43B
Investing cash flow	-$1.57B	$5.86B	-$774.00M	-$3.20B	-$2.87B	-$1.66B	-$3.49B	-$2.37B	-$1.94B	-$2.93B
Financing cash flow	-$3.28B	-$11.95B	-$5.43B	-$4.20B	-$4.14B	-$5.34B	-$4.96B	-$4.45B	-$4.36B	-$4.75B
Dividends paid	$2.38B	$2.49B	$2.69B	$2.89B	$3.12B	$3.38B	$3.62B	$3.67B	$3.59B	$3.64B
Share buybacks	$3.54B	$2.17B	$2.88B	$1.33B	$652.00M	$2.54B	$645.00M	$2.14B	$3.23B	$1.03B
Stock-based compensation	$348.00M	$344.00M	$290.00M	$297.00M	$344.00M	$359.00M	$355.00M	$393.00M	$429.00M	$457.00M
Depreciation & amortization	$2.92B	$2.64B	$2.66B	$2.66B	$2.70B	$2.71B	$2.70B	$2.65B	$2.86B	$2.96B

Income statement

quarters · USD

Quarter ended	Oct 2023	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026	Apr 2026	Jul 2026
Revenue	$7.98B	$8.09B	$8.59B	$7.92B	$8.40B	$8.29B	$8.93B	$8.58B	$8.96B	$9.02B	$9.81B	$9.76B
Cost of revenue	$2.76B	$2.78B	$3.04B	$2.76B	$2.95B	$2.78B	$3.15B	$3.00B	$3.06B	$3.26B	$3.40B	$3.42B
Gross profit	$5.22B	$5.31B	$5.54B	$5.15B	$5.46B	$5.51B	$5.78B	$5.58B	$5.90B	$5.76B	$6.41B	$6.34B
Research & development	$698.00M	$695.00M	$675.00M	$676.00M	$697.00M	$675.00M	$684.00M	$726.00M	$754.00M	$722.00M	$671.00M	$771.00M
Selling, general & admin	$2.69B	$2.67B	$2.77B	$2.65B	$2.76B	$2.72B	$2.72B	$2.81B	$2.96B	$2.96B	$3.06B	$3.20B
Operating income	$1.34B	$1.48B	$1.05B	$1.28B	$1.59B	$1.65B	$1.44B	$1.45B	$1.69B	$1.46B	$1.87B	$1.76B
Interest expense	$180.00M	$188.00M	$202.00M	$167.00M	$209.00M	$179.00M	$174.00M	$176.00M	$181.00M	$181.00M	$176.00M	$186.00M
Pre-tax income	$1.31B	$1.47B	$855.00M	$1.27B	$1.56B	$1.54B	$1.26B	$1.30B	$1.60B	$1.40B	$1.83B	$1.77B
Income tax	$402.00M	$135.00M	$197.00M	$220.00M	$281.00M	$237.00M	$199.00M	$255.00M	$215.00M	$254.00M	$575.00M	$289.00M
Net income	$909.00M	$1.32B	$654.00M	$1.04B	$1.27B	$1.29B	$1.06B	$1.04B	$1.37B	$1.14B	$1.24B	$1.47B
EBITDA	$2.01B	$2.13B	$1.71B	$1.94B	$2.27B	$2.33B	$2.28B	$2.19B	$2.43B	$2.21B	$2.59B	$2.49B
EPS (basic)	$0.68	$0.99	$0.50	$0.81	$0.99	$1.01	$0.83	$0.81	$1.07	$0.89	$0.98	$1.15
EPS (diluted)	$0.68	$0.99	$0.49	$0.80	$0.99	$1.01	$0.82	$0.81	$1.07	$0.89	$0.97	$1.14
Diluted shares	1.33B	1.33B	-2.20M	1.30B	1.29B	1.29B	-700.00K	1.29B	1.29B	1.29B	-100.00K	1.29B
Gross margin	65.4%	65.6%	64.6%	65.1%	64.9%	66.5%	64.7%	65.0%	65.8%	63.8%	65.4%	65.0%
Operating margin	16.8%	18.3%	12.3%	16.1%	19.0%	19.9%	16.1%	16.8%	18.8%	16.2%	19.1%	18.1%
Net margin	11.4%	16.3%	7.6%	13.2%	15.1%	15.6%	11.8%	12.1%	15.3%	12.7%	12.7%	15.1%

Balance sheet

quarters · USD

Quarter ended	Oct 2023	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026	Apr 2026	Jul 2026
Cash & equivalents	$1.31B	$1.62B	$1.28B	$1.31B	$1.39B	$1.24B	$2.22B	$1.27B	$1.28B	$1.15B	$1.95B	$1.69B
Short-term investments	$6.42B	$6.70B	$6.72B	$6.53B	$6.59B	$6.68B	$6.75B	$6.85B	$7.04B	$7.24B	$7.27B	$7.13B
Receivables	$5.93B	$5.97B	$6.13B	$6.01B	$6.26B	$6.12B	$6.51B	$6.26B	$6.39B	$6.36B	$6.64B	$6.36B
Inventory	$5.75B	$5.73B	$5.22B	$5.41B	$5.48B	$5.61B	$5.48B	$5.89B	$6.16B	$6.31B	$5.95B	$6.21B
Total current assets	$22.08B	$22.51B	$21.93B	$21.95B	$22.44B	$22.51B	$23.81B	$23.22B	$24.00B	$24.07B	$24.79B	$24.39B
Goodwill	$40.82B	$41.16B	$40.99B	$41.08B	$41.16B	$40.82B	$41.74B	$42.01B	$41.81B	$41.89B	$42.59B	$43.19B
Total assets	$90.09B	$90.84B	$89.98B	$89.75B	$90.04B	$89.97B	$91.68B	$90.97B	$91.35B	$91.48B	$93.03B	$93.31B
Total current liabilities	$9.66B	$9.79B	$10.79B	$10.29B	$12.20B	$11.84B	$12.88B	$11.53B	$9.94B	$9.49B	$11.66B	$11.80B
Short-term debt	$1.34B	$1.03B	$1.09B	$1.55B	$3.72B	$2.62B	$2.87B	$2.43B	$1.42B	$191.00M	$1.79B	$2.54B
Long-term debt	$23.74B	$24.15B	$23.93B	$26.31B	$24.61B	$23.98B	$25.64B	$26.18B	$27.68B	$27.88B	$26.17B	$25.62B
Total debt	$25.08B	$25.18B	$25.02B	$27.86B	$28.33B	$26.61B	$28.52B	$28.61B	$29.10B	$28.07B	$27.96B	$28.15B
Total liabilities	$38.44B	$38.84B	$39.56B	$41.59B	$41.33B	$40.36B	$43.42B	$42.84B	$42.49B	$42.29B	$42.96B	$42.46B
Shareholders' equity	$51.46B	$51.79B	$50.21B	$47.95B	$48.49B	$49.39B	$48.02B	$47.89B	$48.65B	$48.98B	$49.46B	$50.23B

Cash flow

quarters · USD

Quarter ended	Oct 2023	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026	Apr 2026	Jul 2026
Operating cash flow	$661.00M	$2.47B	$2.78B	$986.00M	$958.00M	$2.57B	$2.53B	$1.09B	$925.00M	$2.74B	$2.57B	$1.79B
Capital expenditures	$461.00M	$346.00M	$426.00M	$520.00M	$404.00M	$476.00M	$459.00M	$504.00M	$468.00M	$444.00M	$488.00M	$503.00M
Free cash flow	$200.00M	$2.13B	$2.35B	$466.00M	$554.00M	$2.10B	$2.07B	$584.00M	$457.00M	$2.30B	$2.08B	$1.29B
Investing cash flow	-$424.00M	-$707.00M	-$696.00M	-$259.00M	-$345.00M	-$843.00M	-$490.00M	-$719.00M	-$482.00M	-$816.00M	-$917.00M	-$1.62B
Financing cash flow	-$90.00M	-$1.50B	-$2.36B	-$731.00M	-$534.00M	-$1.75B	-$1.34B	-$1.38B	-$395.00M	-$2.09B	-$888.00M	-$343.00M
Dividends paid	$918.00M	$917.00M	$913.00M	$898.00M	$897.00M	$897.00M	$897.00M	$910.00M	$910.00M	$911.00M	$908.00M	$921.00M
Share buybacks	$226.00M	$132.00M	$1.63B	$2.49B	$288.00M	$181.00M	$274.00M	$123.00M	$372.00M	$105.00M	$435.00M	$267.00M
Stock-based compensation	$146.00M	$84.00M	$90.00M	$83.00M	$159.00M	$98.00M	$89.00M	$86.00M	$182.00M	$94.00M	$95.00M	$125.00M
Depreciation & amortization	$672.00M	$649.00M	$654.00M	$662.00M	$675.00M	$684.00M	$840.00M	$748.00M	$745.00M	$749.00M	$716.00M	$729.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.